Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Taro Pharmaceutical Indus Q1 EPS $0.37 Down From $1.09 YoY, Sales $156.66M Up From $147.11M YoY

Author: Benzinga Newsdesk | July 27, 2022 05:30pm
Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.37 per share. This is a 66.06 percent decrease over earnings of $1.09 per share from the same period last year. The company reported $156.66 million in sales this quarter. This is a 6.49 percent increase over sales of $147.11 million the same period last year.

Posted In: TARO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist